Scott Sherriff
Directeur des opérations chez AROA BIOSURGERY LIMITED
Profil
Scott Sherriff has worked as the Chief Operating Officer at Aroa Biosurgery Ltd.
since 2023.
Prior to his current position, he served as the Global Head of Women's Healthcare at Bayer AG from 2012 to 2015 and as the Global Head of Hypertension at Novartis AG from 2011 to 2012.
From 2015 to 2023, he held the role of Chief Commercial Officer at Douglas Pharmaceuticals Ltd.
Mr. Sherriff holds an MBA from INSEAD and an undergraduate degree from Victoria University of Wellington.
Postes actifs de Scott Sherriff
Sociétés | Poste | Début |
---|---|---|
AROA BIOSURGERY LIMITED | Directeur des opérations | 01/07/2023 |
Anciens postes connus de Scott Sherriff
Sociétés | Poste | Fin |
---|---|---|
Douglas Pharmaceuticals Ltd.
Douglas Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Douglas Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products include acitretin capsules, anastrozole tablets, Azathioprine film-coated tablets, Clozapine tablets, Dutasteride, Quetiapinetablets and Rivastigmine capsules. The company was founded by Graeme Bruce Douglas in 1967 and is headquartered in Auckland, New Zealand. | Corporate Officer/Principal | 01/06/2023 |
BAYER AG | Corporate Officer/Principal | 01/01/2015 |
NOVARTIS AG | Corporate Officer/Principal | 01/06/2012 |
Formation de Scott Sherriff
INSEAD | Masters Business Admin |
Victoria University of Wellington | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
BAYER AG | Health Technology |
NOVARTIS AG | Health Technology |
AROA BIOSURGERY LIMITED | Health Technology |
Entreprise privées | 1 |
---|---|
Douglas Pharmaceuticals Ltd.
Douglas Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Douglas Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products include acitretin capsules, anastrozole tablets, Azathioprine film-coated tablets, Clozapine tablets, Dutasteride, Quetiapinetablets and Rivastigmine capsules. The company was founded by Graeme Bruce Douglas in 1967 and is headquartered in Auckland, New Zealand. | Health Technology |